Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Iaci

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJames E Galvin, Mary E Hamby, Jennifer Iaci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMichael Grundman, Susan Catalano, Mary E Hamby, et al.
The Journal of Sexual Medicine|February 3, 2015
GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunctionArthur L Burnett, Sena F Sezen, Ahmet Hoke, et al.
Journal of Alzheimer'S Disease : JAD|April 3, 2026
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's diseaseEverard G B Vijverberg, Douglas W Scharre, Michael Woodward, et al.
JACC. Basic to Translational Science|September 1, 2018
A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart FailureDaniel J Lenihan, Sarah A Anderson, Carrie Geisberg Lenneman, et al.
Plos One|February 26, 2013
Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarctionMichael F Hill, Amish V Patel, Abigail Murphy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJames E Galvin, Mary E Hamby, Jennifer Iaci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMichael Grundman, Susan Catalano, Mary E Hamby, et al.
The Journal of Sexual Medicine|February 3, 2015
GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunctionArthur L Burnett, Sena F Sezen, Ahmet Hoke, et al.
Journal of Alzheimer'S Disease : JAD|April 3, 2026
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's diseaseEverard G B Vijverberg, Douglas W Scharre, Michael Woodward, et al.
JACC. Basic to Translational Science|September 1, 2018
A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart FailureDaniel J Lenihan, Sarah A Anderson, Carrie Geisberg Lenneman, et al.
Plos One|February 26, 2013
Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarctionMichael F Hill, Amish V Patel, Abigail Murphy, et al.
Pageof 1